Category Archives: TB

What we’re reading: Before the 49th Union World Conference on Lung Health, we’re reading how fair pricing and policies can end TB

By on .

With the 49th Union World Conference on Lung Health about to open in the Hague Wednesday, with a theme of “Declaring Our Rights: Social and Political Solutions,” befitting the city of justice, we’re reading how fair pricing and responsive policies can speed progress against an ancient disease. And stay tuned — Science Speaks will be […]

DRC prison TB outbreak brings conditions, risks to wider community, to light

By on .

At a prison where more than one in five inmates was confirmed to be sick with TB, an outbreak investigation sparked recommendations for reforms With a large stock of soon-to-expire Xpert cartridges, at the end of 2014 the diagnostic laboratory near the Democratic Republic of Congo’s Mbuji-Mayi medium security prison started using the technology for […]

Fighting TB starts with data

By on .

The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight tuberculosis: the Global Accelerator to End TB, a business model to treat 40 million people by 2022 through performance-based investments. One of USAID’s initial efforts on this front is […]

Bangladesh, USAID DR TB treatment project shows impacts of community-based approach

By on .

A project that shifted treatment for drug-resistant tuberculosis from overburdened Bangladesh hospitals to patients’ homes saw time between diagnosis and treatment initiation drop from more than three months to less than a week, reducing risks of the continued spread of the disease, a study reported in Global Health Science and Practice found. In the process, researchers […]

WHO 2018 global TB report presented as agenda for UN meeting, commitments

By on .

In 2017, around the world as many as 4,000 people died of tuberculosis on any given day. That added up to an estimated — give or take several hundred thousand lives — 1.3 million people killed by a curable disease. An estimated 10 million people developed tuberculosis — a disease that also is preventable. The […]

Delamanid delay comes home

By on .

Patient benefits from access to innovative drug that still awaits U.S. approval A note from the field in this week’s Morbidity and Mortality Weekly Report describes the case of a dangerously ill man in the United States. Weak, coughing, and losing weight, with pain in his chest, he was tested for tuberculosis, which it turned […]

TB treatment trial aims to consign lengthier, more toxic regimens to history

By on .

With the enrollment of its first patients in Eastern Europe, the largest trial yet to test a four-drug, four-month treatment regimen against tuberculosis will set out to demonstrate whether fewer medicines, over a shorter length of time can cure nearly all TB patients. The trial, which will launch in Tbilisi, the capital of the country of […]

WHO recommends superior, injection-free regimen for drug-resistant TB

By on .

New, more effective medicines replace painful daily shots, drugs causing psychosis, permanent hearing loss; TB and medical communities welcome change, say recommended drugs must be accessible, affordable Saying rates of cured cases of drug-resistant tuberculosis could be increased with access to an oral regimen of newer, more effective and less toxic medicines, the World Health Organization […]

Advocates hail South Africa bedaquiline recommendation, replacing toxic injection for patients with drug-resistant tuberculosis

By on .

Medicine represents third choice over “deaf or dead” for many patients, health worker/tuberculosis survivor-founded organization says Praising the treatment policy decision of South Africa health officials to replace painful injections that brought irreversible side effects to many tuberculosis patients whose disease was resistant to first line treatments with a newer medicine that had been proven […]